Back to Trades
Grant4
AMGEN INC
AMGN
Total Value
$0
Company Information
- Company Name
- AMGEN INC
- Ticker Symbol
- AMGN
- CIK
- 0000318154
Insider Information
- Name
- Bradway Robert A
- Role
- Chairman, CEO and President, Director
- Location
- THOUSAND OAKS, CA
DirectorOfficer
Filing Details
- Filing Date
- Mar 5, 2026
- Transaction Date
- Mar 3, 2026
- Accession Number
- 0000318154-26-000014
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | 42,657 | — | Grant/Award | — |
Footnotes
- (F1)These shares include 2,414 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.